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Introduction: Hypertensive encephalopathy is one cause of posterior reversible encephalopathy syndrome.
Hypertensive encephalopathy and cerebral infarction have only been reported in a few individual case reports.
Case description: A 51-year-old woman presented with hypertensive encephalopathy. T2-weighted images from
magnetic resonance imaging showed hyperintense lesions in both occipital and parietal lobes. Diffusion-weighted
imaging showed that this represented cytotoxic oedema and perfusion magnetic resonance imaging revealed
reduced blood volume and flow. The magnetic resonance imaging was repeated 5 months later and subtotal
regression of theT2-hyperintensity had occurred. However, small bilateral infarcts were seen on T1-weighted images.
Perfusion magnetic resonance imaging presented reduced blood volume and flow on the right side.
Discussion and evaluation: The patient in this report had posterior reversible encephalopathy syndrome caused
by hypertensive encephalopathy. Magnetic resonance imaging of the brain showed bilateral cytotoxic oedema that
partially resolved and resulted in small infarcts. The imaging findings are compatible with posterior reversible
encephalopathy syndrome with subtotal resolution and infarct evolution.
Conclusion: The case report suggests that the presence of hypertensive encephalopathy and posterior reversible
encephalopathy syndrome should alert clinicians and lead to prompt treatment in order to prevent cerebral
damage.
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In 1996, (Hinchey et al. 1996) first described “reversible
posterior leukoencephalopathy syndrome” (RPLS) with
different symptoms and imaging findings in connection
with hypertensive emergency. Posterior reversible enceph-
alopathy syndrome (PRES) is now commonly used to de-
scribe the syndrome (Casey et al. 2000; Covarrubias et al.
2002). Hypertensive encephalopathy (HE) is one cause
of PRES. The clinical presentation is diverse (Hinchey
et al. 1996), which is why the diagnosis can be misjudged.
Symptoms include headache, seizures, vomiting, change
in mental status, and cortical visual disturbances. Differen-
tial diagnoses include central venous thrombosis, enceph-
alitis, demyelinating disorders, stroke and brain tumour.
Apart from HE, PRES has also been associated withCorrespondence: Bengt.Edvardsson@med.lu.se
Department of Clinical Sciences, Lund, Neurology, Skane University Hospital,
Lund University, S-221 85 Lund, Sweden
© 2014 Edvardsson; licensee Springer. This is a
Attribution License (http://creativecommons.or
in any medium, provided the original work is ppre-eclampsia/eclampsia (Sibai 1996), thrombotic throm-
bocytopenic purpura/haemolytic uraemic syndrome
(Bakshi et al. 1999), cyclosporine A treatment (Gijtenbeek
et al. 1999), tacrolismus, interferon alpha-2 and many
other conditions.
Computed tomography (CT) typically shows hypodense
foci in both parietal and occipital lobes. MRI shows hy-
perintense lesions on T2-weighted images, in the same
regions, reflecting cortical/subcortical oedema with predi-
lection for the posterior circulation (Sanders et al. 1991).
Diffusion weighted imaging (DWI) usually shows increased
diffusion consistent with vasogenic oedema (Schaefer et al.
1997; Schwartz et al. 1998; Ahn et al. 2004).
I present a patient who presented with HE and sub-
sequently developed PRES with cytotoxic oedema with
subtotal regression and development of small infarctions.
I postulate that her HE/PRES was related to severe hyper-
tension with fluctuating blood pressure. PRES caused byn Open Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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tion is seldom described in individual reports.
Case description
A 51-year-old, previously healthy, woman experienced
headache. Blood pressure had been monitored about one
year earlier and she had been normotensive. At the time
of admission she had hypertension with a blood pressure
of 220/110 mmHg. CT of the brain was normal and ce-
rebrospinal fluid examination was also normal. A phys-
ical examination showed nothing remarkable except for
high blood pressure. The patient was discharged without
further investigation or treatment. Some days later, she
noticed a tingling sensation in the right part of her body.
This was probably due to a seizure, and she was re-
admitted. She had persistent severe headache on the
days that followed, intermittently requiring morphine.
Nausea and vomiting occurred frequently, decreased
alertness was observed, and blurred vision gradually de-
veloped. Treatment with phenytoin and levetiracetam
intravenously proved to be effective and the seizures
stopped. Her blood pressure fluctuated, reaching 230/
110 mmHg, but a diagnosis of hypertension was confirmed
and treatment started. The hypertension was treated with
labetalol and enalaprilat intravenously. After three days,
the patient suddenly developed a left-sided hemiparesis
and a left-sided hemianopia. The blood pressure at theFigure 1 Primary MRI, T2-weighted image.time of symptom onset was reduced to 190/100 mmHg.
MRI, T2-weighted images showed hyperintensity in both
occipital and parietal lobes (Figure 1). DWI (Figure 2) re-
veals rather extensive areas with high signal intensity with
low signal on the ADC map (Figure 3) reflecting cytotoxic
oedema in both occipital and parietal lobes. PWI showed
slightly reduced blood flow on the right side (Figure 4).
Coronal T2-weighted FLAIR image shows the bilateral
high signal intensity oedema. There was a small hemor-
rhagic component in the left occipital lobe and adjacent to
it there was a small area with high signal (Figure 5). Mag-
netic resonance angiography (MRA) displayed no signs of
vasospasm or intracranial/extracranial stenosis. Complete
blood picture, and blood biochemistry were essentially
normal. An electroencephalogram (EEG) was ordered and
showed diffuse slowing indicating an encephalopathy.
Echocardiography was essentially normal. Repeated elec-
trocardiograms were normal. Her blood pressure improved
and was 150/100 when the patient was discharged. Her
symptoms diminished but she had residual hemianopia.
On follow-up MRI 5 months later, the T2-weighted
images showed subtotal regression of the hyperintense
lesions in both occipital lobes, and small areas consistent
with infarctions had developed bilaterally (Figures 6, 7, 8,
9 and 10). An extensive clinical work-up has not provided
any explanation for the hypertensive crisis that caused
her encephalopathy. All secondary causes as renal artery
Figure 2 Primary DWI.
Figure 3 Primary ADC map.
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Figure 4 Primary PWI.
Figure 5 Primary coronal T2-weighted FLAIR image.
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Figure 6 MRI after 5 months, T2-weighted image.
Figure 7 DWI after 5 months.
Edvardsson SpringerPlus 2014, 3:741 Page 5 of 9
http://www.springerplus.com/content/3/1/741
Figure 8 ADC map after 5 months.
Figure 9 Coronal FLAIR after 5 months.
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Figure 10 MRI after 5 months, transverse T1-weighted image after contrast injection.
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renal tumours, coarctation of the aorta and obstructive
sleep apnoea were ruled out. A diagnosis of essential
hypertension was established. The patient is currently
asymptomatic except for residual hemianopia and her
blood pressure varies within the normal range. She is
continuing with antihypertensive treatment.
Discussion
The patient in this report had PRES caused by hyperten-
sive encephalopathy. MRI of the brain showed bilateral
cytotoxic oedema that partially resolved and resulted in
small infarcts.
The pathophysiology of PRES is not fully understood,
but there are two main theories. One postulates that
severe hypertension breaks cerebral autoregulation, lea-
ding to cerebral vasodilatation/hyperperfusion and sub-
sequently to vasogenic cerebral oedema (Hinchey et al.
1996). The hyperperfusion hypothesis seems to be the
most applicable in this case of PRES. The alternative hy-
pothesis postulates endothelial dysfunction caused by cir-
culating toxins such as immunosuppressive drugs, sepsis
and cytotoxic agents leading to cerebral vasoconstriction/
hypoperfusion and subsequent blood–brain barrier dysfunc-
tion and secondary vasogenic oedema (Legriel et al. 2011).
The hallmark of PRES is involvement of the posterior
part of the cerebral hemispheres. The imaging modality
of choice is MRI, typically revealing vasogenic oedema
in the subcortical white matter, often also extending intothe cortical grey matter. The good outcome that the term
PRES implies is not always achieved: fatal and adverse
outcome was seen in up to 26% of cases in one report
(Covarrubias et al. 2002). In another article, (Li et al.
2012) reported permanent neurologic deficits in 24% of
cases in a retrospective review of RPLS. Cerebral dam-
age can be prevented by immediate treatment of PRES,
when it is diagnosed as the underlying mechanism
(Ay et al. 1998; Mukherjee and Mc Kinstry 2001).
Studies of PRES usually show diffuse MRI signal chan-
ges with increased diffusion, consistent with vasogenic
oedema, but cytotoxic oedema has also been reported.
Most often cytotoxic oedema was found in a single or few
patients and in small areas within lesions predominantly
representing vasogenic oedema (Covarrubias et al. 2002;
Mukherjee and Mc Kinstry 2001: Seneviratne et al. 2005).
HE/PRES is usually reversible by control of blood pres-
sure or removal of the underlying cause (Mirza 2006).
Consequently, case reports of HE and PRES associated
with cerebral infarction are uncommon. (Liang et al. 2013)
described a patient with an isolated brainstem variant of
PRES complicated with ischemic stroke. Severe hyperten-
sion was noticed. Hypertensive brainstem encephalopathy
is earlier reported and it is usually reversible. (Mak et al.
2004) reported two patients with posterior circulation is-
chemic strokes associated with HE and blood pressure
lowering. However, there are more reports demonstra-
ting resolution of ischemic changes in HE/PRES. The
resolution of changes seen in these cases is probably
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et al. 2004).
The patient described in the present report differs
from the typical patient. Several imaging findings impli-
cated an unfavourable outcome. She had early changes
with extensive T2 abnormalities, indicating an adverse
outcome (Covarrubias et al. 2002). Focal parenchymal
haemorrhages most likely predict permanent clinical
symptoms (Hefzy et al. 2009). Massive oedema was seen
which could impair the microcirculation and lead to is-
chaemia (Ay et al. 1998). Restricted diffusion, i.e. cytotoxic
oedema, is usually indicative of progress to cerebral in-
farction, as happened with our patient (Casey et al. 2000;
Covarrubias et al. 2002; Ay et al. 1998). However, large
portions of the areas with cytotoxic oedema were rever-
sible. Perfusion was reduced, which can be an ominous
sign (Sundgren et al. 2002; Ay et al. 1998). The reversibil-
ity of PRES is not spontaneous. A delay in diagnosis and
treatment may lead to permanent damage (Casey et al.
2000; Covarrubias et al. 2002). Ischemia is a known com-
plication of PRES occurring characteristically in the pos-
terior part of the brain (Covarrubias et al. 2002).
The currently existing definition of hypertensive emer-
gency is a blood pressure higher than 180/120 mmHg.
The blood pressure must also be associated with end
organ dysfunction as HE (Papadopoulos et al. 2010). In
this case, the patient was previously healthy with no
known hypertension; this is probably the reason for her
sensitivity to increasing blood pressure and development
of HE. Interestingly, patients without previous hyperten-
sion are more likely to develop acute HE even when the
blood pressure does not reach values greater than 180/
120 mmHg, because of no protective secondary changes
in end-organs. Such changes are common in patients
with chronic hypertension (Skinhoj and Strandgaard
1973). The fluctuating nature of the blood pressure can
also contribute to the development of HE (de Seze et al.
2000).
Conclusions
I present a patient who presented with HE and sub-
sequently developed PRES with cytotoxic oedema with
subtotal regression and development of small infarctions.
The clinician should be vigilant and aware of this syn-
drome and act promptly when a patient presents with
such symptoms in order to prevent cerebral damage.
HE/PRES should be included on the list of uncommon
causes of stroke.
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